NicholasASalaDO

PubMed

• 31 citations
  Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years.
  Michael X. Repka, Raymond T. Kraker, Roy W. Beck, C. Scott Atkinson, Darron A. Bacal
  Archives of Ophthalmology. 2010-09-01
• 148 citations
  A randomized trial of atropine regimens for treatment of moderate amblyopia in children.
  Michael X. Repka, Susan A. Cotter, Roy W. Beck, Raymond T. Kraker, Eileen E. Birch
  Ophthalmology. 2004-11-01
• 6 citations
  Feasibility of a clinical trial of vision therapy for treatment of amblyopia
  Don W. Lyon, K. Hopkins, Raymond H. Chu, Susanna M. Tamkins, Susan A. Cotter
  Optometry and Vision Science. 2013-05-01

Journal Articles

• Balloon catheter dilation and nasolacrimal duct intubation for treatment of nasolacrimal duct obstruction after failed probing  
  Pediatric Eye Disease Investigator Group, Arch Ophthalmol, 1/1/2009
• Repeat probing for treatment of persistent nasolacrimal duct obstruction  
  Pediatric Eye Disease Investigator Group, J AAPOS, 1/1/2009
• Pharmacologic plus optical penalization treatment for amblyopia: results of a randomized trial  
  Pediatric Eye Disease Investigator Group, Arch Ophthalmol, 1/1/2009
• The relationship between preoperative alignment stability and postoperative motor outcomes in children with esotropia  
  Pediatric Eye Disease Investigator Group, J AAPOS, 1/1/2009
• Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial  
  Pediatric Eye Disease Investigator Group, Arch Ophthalmol, 1/1/2008
• A randomized trial of near versus distance activities while patching for amblyopia in children aged 3 to less than 7 years  
  Pediatric Eye Disease Investigator Group, Ophthalmology, 1/1/2008
• Interobserver reliability of the Prism and Alternate Cover Test in children with esotropia  
  Pediatric Eye Disease Investigator Group, Ophthalmology, 1/1/2008
• A randomized trial of atropine vs patching for treatment of moderate Amblyopia: follow-up at age 10 years  
  Pediatric Eye Disease Investigator Group, Arch Ophthalmol, 1/1/2008
• Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age  
  Pediatric Eye Disease Investigator Group, J AAPOS, 1/1/2008
• Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age  
  Pediatric Eye Disease Investigator Group, J AAPOS, 1/1/2008
• Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years  
  Pediatric Eye Disease Investigator Group, Ophthalmology, 1/1/2008
• Treatment of bilateral refractive amblyopia in children three to less than 10 years of age  
  Pediatric Eye Disease Investigator Group, Am J Ophthalmol, 1/1/2007
• Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years  
  Pediatric Eye Disease Investigator Group, Arch Ophthalmol, 1/1/2007
• Treatment of strabismic amblyopia with refractive correction  
  Pediatric Eye Disease Investigator Group, Am J Ophthalmol, 1/1/2007
• Treatment of anisometropic amblyopia in children with refractive correction  
  Pediatric Eye Disease Investigator Group, Ophthalmology, 1/1/2006
• A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children  
  Pediatric Eye Disease Investigator Group, Ophthalmology, 1/1/2006
• Two-year follow-up of a 6 month randomized trial of atropine vs patching for treatment of moderate Amblyopia in children  
  Pediatric Eye Disease Investigator Group, Arch Ophthalmol, 1/1/2005
• A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia  
  Pediatric Eye Disease Investigator Group, J AAPOS, 1/1/2005
• Randomized trial of treatment of amblyopia in children aged 7 to 17 years  
  Pediatric Eye Disease Investigator Group, Arch Ophthalmol, 1/1/2005
• A randomized trial of atropine regimens for treatment of moderate amblyopia in children  
  Pediatric Eye Disease Investigator Group, Ophthalmology, 1/1/2004
• A prospective, pilot study of treatment of amblyopia in children 10 to < 18 years old  
  Pediatric Eye Disease Investigator Group, Am J Ophthalmol, 1/1/2004
• Risk of amblyopia recurrence after cessation of treatment  
  Pediatric Eye Disease Investigator Group, J AAPOS, 1/1/2004
• A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia and other factors.  
  Pediatric Eye Disease Investigator Group, Ophthalmology, 1/1/2003
• The course of moderate Amblyopia treated with patching in children: experience of the amblyopia treatment study  
  Pediatric Eye Disease Investigator Group, Arch Ophthalmol, 1/1/2003
• Impact of patching and atropine treatment on the child and family in the Amblyopia treatment study  
  Pediatric Eye Disease Investigator Group, Arch Ophthalmol, 1/1/2003
• Join now to see all

Books/Book Chapters

• 9th Meeting of the International Strabismological Association 
  Chapter: Moderate Amblyopia in children less than seven years of age: experience of the Amblyopia treatment study 1 
  Page 163 - 166Repka MX, Pediatric Eye Disease Investigator GroupEditors: de Faber J-T, ed.Sweta & Zeitlinger Publishers, Sydney, Australia2003

Lectures

• Adult Strabismus – Myths and Misconceptions 
  Multiple Locations, 2006, 2007, 2008 - 5/1/2008
• Balloon Dacryocystoplasty 
  2002; 2008 - 1/1/2008
• What is PEDIG? 
  4/1/1999
• Adult Strabismus - What’s New? 
  1995; 1997 - 4/1/1997
• Pediatric Ophthalmology Curriculum 
  1/1/1995
• Compensatory Head Posturing 
  10/1/1994
• Vision testing in the pre-verbal and pre-literate Child 
  Erie, PA, 1993, 1994 - 8/1/1994
• Corneal Opacification in Childhood 
  4/1/1994
• Orbital Tumors of Childhood 
• Join now to see all